	销售和管理费用		日
Akebia Therapeutics	USD 23.53M	3.19M	2025-12
Alaunos Therapeutics	USD 585K	84K	2025-09
Avita Medical	AUD 19.03M	1.95M	2025-12
Clinuvel Pharmaceuticals	AUD 3.85M	5.27M	2025-12
Dianthus Therapeutics	USD 6.57M	1.62M	2025-12
Genetic Signatures	AUD 908K	31K	2025-12
Ionis Pharmaceuticals	USD 130M	43.43M	2025-12
Medical Developments International	AUD 2.84M	4.19M	2025-12
Neuren Pharmaceuticals	AUD 3.74M	2.5M	2025-12
Organon & Co	USD 399M	54M	2025-09
Paradigm Biopharmaceuticals	AUD 2.83M	1.22M	2025-12
PYC Therapeutics	AUD 328.4K	1.8M	2025-12
Starpharma Holdings	AUD 4.42M	2.86M	2025-12
Tectonic Therapeutic	USD 3.44M	1.52M	2025-12
Telix Pharmaceuticals	AUD 93.48M	1.04M	2025-12
Viatris	USD 1.03B	144.1M	2025-12
Xeris Pharmaceuticals	USD 42.64M	3.82M	2025-12